Gliadin peptides

Piper, J. L., Gray, G. M., and Khosla, C. (2002). High selectivity of human tissue transglutaminase for immunoactive gliadin peptides Implications for celiac sprue. Biochemistry 41, 386-393. 

Aleanzi, M., Demonte, A.M., Esper, C., Garcilazo, S., Waggener, M. 2001. Celiac disease Antibody recognition against native and selectively deaminated gliadin peptides. Clin Chem 47 2023-2028. 

Di Cagno, R., De Angelis, M., Lavermicocca, P., De Vincenzi, M., Giovannini, C., Faccia, M., Gobbetti, M. 2002. Proteolysis by sourdough lactic acid bacteria Effects on wheat flour protein fractions and gliadin peptides involved in human cereal intolerance. Appl Environ Microbiol 68 623-633. 

Hausch, F., Shan, L., Santiago, N.A., Gray, G.M., Khosla, C. 2003. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol 283 996-1003. 

Popineau, Y. and Pineau, F. 1993. Emulsifying properties of wheat gliadins and gliadin peptides In Food Proteins. Structure and Functionality (K.D. Schwenke and R. Mothes eds), pp. 290-296. VCH, Weinheim. 

DEAMIDATED GLIADIN PEPTIDES AS TARGETS FOR CELIAC DISEASE-SPECIFIC ANTIBODIES... 

Kahlenberg F, Sanchez D, Lachmann I, Tuckova L, Tlaskalova H, Mendez E, et al. Monoclonal antibody R5 for detection of putatively coeliac-toxic gliadin peptides. Eur Food Res Technol 2006 222 78-82. 

Piper JL, Gray GM, Khosla C. Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo. J Pharmacol Exp Ther 2004 311 213-219. 

Matysiak-Budnik T, Candalh C, Cellier C, Dugave C, Namane A, Vidal-Martinez T, et al. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Gastroenterology 2005 129 786-796. 

Stern M, Gellermann B, Belitz H-D, Wieser H. Food proteins and maturation of small intestinal microvillus membranes (MVM). II. Binding of gliadin hydrolysate fractions and of the gliadin peptide B3142. J Pediatr Gastroenterol Nutr 1988 7 122-127. 

Zimmer KP, Naim H, Weber P, Ellis HJ, Ciclitira PJ. Targeting of gliadin peptides, CD8, alpha/beta-TCR, and gamma/delta-TCR to Golgi complexes and vacuoles within celiac disease enterocytes. FASEB J 1998 12 1349-1357. 

Molberg O, Mcadam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by Gut-derived T cells in celiac disease. Nat Med 1998 4 713-717. Erratum in Nat Med 1998 4 974. 

Skovbjerg H, Koch C, Anthonsen D, Sjostrom H. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease. Biochim Biophys Acta 2004 1690 220-230. 

Mazzarella G, Maglio M, Paparo F, Nardone G, Stefanile R, Greco L, et al. An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients. Gut 2003 52 57-62. 

Lahdeaho ML, Vainio E, Lehtinen M, Parkkonen P, Partanen J, Koskimies S, et al. Activation of celiac disease immune system by specific o-gliadin peptides. Cereal Chem 1995 72 475 179. 

Prince HE. Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Clin Vaccine Immunol 2006 13 150-151. 

Mamone G, Ferranti P, Melck D, Tafuro F, Longobardo L, Chianese L, et al. Susceptibility to transglutaminase of gliadin peptides predicted by a mass spectrometry-based assay. FEBS Lett 2004 562 177-182. 

---